A common variant of CDKN2A (p16) predisposes to breast cancer

被引:61
|
作者
Debniak, T
Górski, B
Huzarski, T
Byrski, T
Cybulski, C
Mackiewicz, A
Gozdecka-Grodecka, S
Gronwald, J
Kowalska, E
Haus, O
Grzybowska, E
Stawicka, M
Swiec, M
Urbanski, K
Niepsuj, S
Wasko, B
Gózdz, S
Wandzel, P
Szczylik, C
Surdyka, D
Rozmiarek, A
Zambrano, O
Posmyk, M
Narod, SA
Lubinski, J
机构
[1] Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada
[2] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland
[3] Dept Canc Immunol, Poznan, Poland
[4] Dept Clin Genet, Bydgoszcz, Poland
[5] Maria Sklodowska Curie Inst, Dept Tumour Biol, Gliwice, Poland
[6] Prophylact & Epidemiol Ctr, Poznan, Poland
[7] Reg Oncol Hosp, Opole, Poland
[8] Reg Oncol Ctr, Krakow, Poland
[9] Reg Oncol Hosp, Olsztyn, Poland
[10] Reg Hosp, Rzeszow, Poland
[11] Holycross Oncol Ctr, Kielce, Poland
[12] Reg Hosp, Bielsko Biala, Poland
[13] Mil Hosp, Warsaw, Poland
[14] Reg Hosp, Lublin, Poland
[15] Reg Oncol Hosp, Zielona Gora, Poland
[16] Reg Hosp, Lodz, Poland
[17] Reg Oncol Hosp, Bialystok, Poland
关键词
D O I
10.1136/jmg.2005.031476
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: A common missense variant of the CDKN2A gene (A148T) predisposes to malignant melanoma in Poland. An association between malignant melanoma and breast cancer has been reported in several families with CDKN2A mutations, Objective: To determine whether this variant also predisposes to breast cancer. Methods: Genotyping was undertaken in 4209 cases of breast cancer, unselected for family history, from 18 hospitals throughout Poland and in 3000 controls. Results: The odds ratio ( OR) associated with the CDKN2A allele for women diagnosed with breast cancer before the age of 50 was 1.5 ( p = 0.002) and after age 50 it was 1.3 ( p = 0.2). The effect was particularly strong for patients diagnosed at or before the age of 30 ( OR = 3.8; p = 0.0002). Conclusions: CDKN2A appears to be a low penetrance breast cancer susceptibility gene in Poland. The association should be confirmed in other populations.
引用
收藏
页码:763 / 765
页数:3
相关论文
共 50 条
  • [21] Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
    Cottone, Lucia
    Eden, Nadia
    Usher, Inga
    Lombard, Patrick
    Ye, Hongtao
    Ligammari, Lorena
    Lindsay, Daniel
    Brandner, Sebastian
    Pizem, Joze
    Pillay, Nischalan
    Tirabosco, Roberto
    Amary, Fernanda
    Flanagan, Adrienne M.
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2020, 6 (02): : 113 - 123
  • [22] MTAP and p16 Immunohistochemistry as Markers for CDKN2A/B Loss in Meningiomas
    Ozkizilkaya, H.
    Ozkizilkaya, H.
    Ogunbona, O. Basit
    Toruner, G.
    Aung, P.
    Esquenazi, Y.
    DeMonte, F.
    Ballester, L.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 546 - 546
  • [23] Methylation: A major cause of p16/CDKN2A inactivation in uveal melanoma
    Metzelaar, JW
    van der Velden, PA
    Gruis, NA
    Hurks, HM
    Ksander, BR
    Jager, MJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S184 - S184
  • [24] CDKN2A (p16(INK4A)) somatic and germline mutations
    SmithSorensen, B
    Hovig, E
    HUMAN MUTATION, 1996, 7 (04) : 294 - 303
  • [25] CDKN2A/p16, RB and CDK4 alterations in osteosarcoma
    Nielsen, GP
    Burns, K
    Rosenberg, AE
    Louis, DN
    MODERN PATHOLOGY, 1998, 11 (01) : 13A - 13A
  • [26] Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas
    Dacic, Sanja
    Kothmaier, Hannelore
    Land, Stephanie
    Shuai, Yongli
    Halbwedl, Iris
    Morbini, Patrizia
    Murer, Bruno
    Comin, Camilla
    Galateau-Salle, Francoise
    Demirag, Funda
    Zeren, Handan
    Attanoos, Richard
    Gibbs, Alan
    Cagle, Philip
    Popper, Helmut
    VIRCHOWS ARCHIV, 2008, 453 (06) : 627 - 635
  • [27] CDKN2A/p16 inactivation is related to pituitary adenoma type and size
    Seemann, N
    Kuhn, D
    Wrocklage, C
    Keyvani, K
    Hackl, W
    Buchfelder, M
    Fahlbusch, R
    Paulus, W
    JOURNAL OF PATHOLOGY, 2001, 193 (04): : 491 - 497
  • [28] Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas
    Sanja Dacic
    Hannelore Kothmaier
    Stephanie Land
    Yongli Shuai
    Iris Halbwedl
    Patrizia Morbini
    Bruno Murer
    Camilla Comin
    Françoise Galateau-Salle
    Funda Demirag
    Handan Zeren
    Richard Attanoos
    Alan Gibbs
    Philip Cagle
    Helmut Popper
    Virchows Archiv, 2008, 453 : 627 - 635
  • [29] Noncoding germline mutations in p16/CDKN2A in melanoma prone families
    Andrew, S
    CLINICAL GENETICS, 1999, 56 (03) : 188 - 190
  • [30] A CDKN2A (p16) Mutation AssociatedWith Familial Pancreatic Cancer Reduces Protein Stability and Functionality
    Horn, I. P.
    Marks, D. L.
    Hogenson, T. L.
    Almada, L. L.
    Goldstein, L. E.
    Duran, P. A. Romecin
    Vrabel, A. M.
    Cui, G.
    Chaffee, K. G.
    Bamlet, W. R.
    Mer, G.
    Li, H.
    Petersen, G. M.
    Fernandez-Zapico, M. E.
    PANCREAS, 2018, 47 (10) : 1393 - 1394